MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

09 Feb 2022 Evaluate
Net sales declined -29.77%  to  Rs. 26230.50 million from Rs. 37351.70 millions.The Company to register a -67.41%  fall in the net profit for the quarter ended December 2021.Operating profit for the quarter ended December 2021 decreased to 3472.00 millions as compared to 11341.20 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 26230.50 37351.70 -29.77 83999.80 117096.60 -28.26 158236.80 133707.70 18.35
Other Income 1312.90 1583.20 -17.07 2576.10 3224.50 -20.11 5898.60 2434.30 142.31
PBIDT 3472.00 11341.20 -69.39 12240.60 34662.70 -64.69 47096.80 29412.90 60.12
Interest 35.40 58.60 -39.59 120.40 227.50 -47.08 286.80 979.10 -70.71
PBDT 3436.60 11282.60 -69.54 12120.20 34435.20 -64.80 46810.00 28433.80 64.63
Depreciation 1012.00 1222.10 -17.19 3140.30 3639.20 -13.71 4879.90 4733.30 3.10
PBT 2424.60 10060.50 -75.90 8979.90 30796.00 -70.84 41930.10 23700.50 76.92
TAX 26.50 2701.40 -99.02 2454.30 8392.30 -70.76 10801.00 4931.70 119.01
Deferred Tax -861.60 17.50 -5023.43 -1088.60 48.70 -2335.32 367.60 8.80 4077.27
PAT 2398.10 7359.10 -67.41 6525.60 22403.70 -70.87 31129.10 18768.80 65.86
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 13.24 30.36 -56.41 14.57 29.60 -50.77 29.76 22.00 35.30
Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..